Clinical Trial Update: Patiromer Trial in CKD Stage IIIB to V [Phase 3]

View source ↗

Summary

A Phase 3 trial of patiromer in chronic kidney disease patients with hyperkalemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Hyperkalemia | Phase 3 | Status: TERMINATED